NTLA - Intellia Therapeutics, Inc.

QQQ $ 613.22 $ -11.61 (-1.86 %)

DIA $ 470.08 $ -3.83 (-0.81 %)

SPY $ 671.96 $ -7.27 (-1.07 %)

TLT $ 89.69 $ 0.80 (0.9 %)

GLD $ 366.89 $ -0.44 (-0.12 %)

Previous Close

$ 12.32

Open

$ 13.48

Bid

$ 9.08 x 1

Ask

$ 9.09 x 43

Day's Range

$ 12.22 - $ 13.51

52 Week Range

$ 5.90 - $ 28.25

Volume

6,236,902

Average Volume

Market Cap

1.32B

Beta (5Y Monthly)

$ 2.33

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-27-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-22-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-26-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	02-27-2020	12-31-2019	10-K
25	10-31-2019	09-30-2019	10-Q
26	08-01-2019	06-30-2019	10-Q
27	05-02-2019	03-31-2019	10-Q
28	02-27-2019	12-31-2018	10-K
29	10-31-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	05-01-2018	03-31-2018	10-Q
32	03-14-2018	12-31-2017	10-K
33	10-31-2017	09-30-2017	10-Q
34	08-01-2017	06-30-2017	10-Q
35	05-02-2017	03-31-2017	10-Q
36	03-14-2017	12-31-2016	10-K
37	11-01-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	06-03-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Intellia Therapeutics Q3 EPS $(0.92) Beats...
11/06/2025 22:05:06

Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(0.92) per share which beat the analyst consensus estimate of...

HC Wainwright & Co. Maintains Buy on Intel...
10/30/2025 16:15:15

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the p...

12 Health Care Stocks Moving In Thursday's...
10/30/2025 12:08:54

meta-ebay-microsoft-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Meta, eBay, Microsoft And Other Big Stocks...
10/30/2025 12:02:45

Market-Moving News for October 30th
10/30/2025 11:16:50

GPRK: 28% | Geopark shares are trading higher after Parex Resources submitted a proposal to acquire all outstanding shares of t...

why-alphabet-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Why Alphabet Shares Are Trading Higher By ...
10/30/2025 09:38:55

intellia-therapeutics-stock-is-diving-again-heres-why

Intellia Therapeutics Stock Is Diving Agai...
10/29/2025 21:57:05

Intellia Therapeutics shares are tumbling in after-hours trading on Wednesday. Here's what you need to know.

12 Health Care Stocks Moving In Wednesday'...
10/29/2025 21:06:30

Intellia Therapeutics Announces That FDA H...
10/29/2025 20:27:30

-SEC Filing

Wells Fargo Downgrades Intellia Therapeuti...
10/28/2025 13:39:27

Wells Fargo analyst Yanan Zhu downgrades Intellia Therapeutics (NASDAQ:NTLA) from Overweight to Equal-Weight and lowers the ...

JMP Securities Maintains Market Outperform...
10/28/2025 13:18:58

JMP Securities analyst Silvan Tuerkcan maintains Intellia Therapeutics (NASDAQ:NTLA) with a Market Outperform and lowers the...

Barclays Maintains Overweight on Intellia ...
10/28/2025 13:05:56

Barclays analyst Gena Wang maintains Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and lowers the price target from ...

nucor-to-rally-more-than-14-here-are-10-top-analyst-forecasts-for-tuesday

Nucor To Rally More Than 14%? Here Are 10 ...
10/28/2025 11:48:22

this-boot-barn-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Boot Barn Analyst Is No Longer Bullis...
10/28/2025 11:23:50

RBC Capital Downgrades Intellia Therapeuti...
10/28/2025 10:14:01

RBC Capital analyst Luca Issi downgrades Intellia Therapeutics (NASDAQ:NTLA) from Outperform to Sector Perform and lowers th...

Bernstein Downgrades Intellia Therapeutics...
10/28/2025 09:57:34

Bernstein analyst William Pickering downgrades Intellia Therapeutics (NASDAQ:NTLA) from Outperform to Market Perform and rai...

B of A Securities Maintains Buy on Intelli...
10/27/2025 17:53:27

B of A Securities analyst Greg Harrison maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the price target...

HC Wainwright & Co. Maintains Buy on Intel...
10/27/2025 17:08:41

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the p...

12 Health Care Stocks Moving In Monday's I...
10/27/2025 17:05:57

gold-falls-3-carters-shares-gain-after-q3-earnings

Gold Falls 3%; Carter's Shares Gain After ...
10/27/2025 17:03:23